Navigation Links
Montana State University offers 6 new biomedical technologies for licensing
Date:8/18/2010

BOZEMAN, Mont. -- Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds.

The technologies are available for licensing to interested companies and entrepreneurs.

The first technology involves an existing clinical drug that was discovered to act as a potent trigger of immune cells. In this role, it could enhance the effectiveness of antibiotics in treating bacterial infections such as Staphylococcus aureus, particularly antibiotic-resistant staph infections.

The drug also shows promise in enhancing the effectiveness of vaccines, particularly those administered to the lungs. The drug is fully approved and commercially available and could be used as a stand-alone therapy or used in combination with other existing antibiotics or vaccines to increase their value. A patent is pending, and the research is ongoing.

The second technology is an extract from a plant commonly known as Fireweed. Epilobium angustifolium produces a compound, oenothein B, which is recognized for its antioxidant, antitumor, antibacterial and antiviral properties. Until now, only limited evidence showed that this compound enhances innate immunity.

MSU research discovered the extract has the potential to bolster the human immune system by activating a number of mechanisms of important disease-fighting cells in the body, phagocytes. Phagocytes have the ability to envelop and devour harmful bacteria, parasites and other substances, and destroy them through a variety of means.

Potential applications of the extract include increasing immunity during bio-warfare threats, flu epidemics, or for travelers who will be exposed to endemic diseases. Benefits of the extract include its potential to rapidly trigger th
'/>"/>

Contact: Evelyn Boswell
evelynb@montana.edu
406-994-5135
Montana State University
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Montana State researchers say Triceratops, Torsaurus were same dinosaur at different stages
2. Montana State grad student to study unique soil around Yellowstone hot springs
3. Montana State University historian wins prize for book on Montana, Utah copper mines
4. Montana State researcher discovers that bile sends mixed signals to E. coli
5. New dinosaur species from Montana
6. Montana State grads work helps diagnose skin cancer without a biopsy
7. Montana State team finds Yellowstone alga that detoxifies arsenic
8. Montana State partnership receives $66.9M for carbon sequestration
9. Montana State researchers receive grant to study algae as a source of biofuel
10. Montana State University researchers find gene that regulates molds resistance to drugs
11. K-State professors cancer research gets boost from National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2015)... May 11, 2015 Fingerprint Cards (FPC) ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... used by smartphone manufacturers in China . ... communicated revenue guidance of + 1 000 MSEK for 2015.   ...
(Date:4/27/2015)... April 27, 2015  For more than four decades, ... has been the premier worldwide event for the unmanned ... a must-attend event for any local, national, or trade ... emerging commercial markets and current applications of unmanned technologies. ... this projected $48 billion industry, and how it will ...
(Date:4/20/2015)... -- The announcement comes as demand for ... (GRM), Ireland,s foremost records management company, ... up an impressive track record of clients within the first ... records management sector in Dubai . As ... and employ a further eight staff members at its Irish ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... America will hold its 93rd annual meeting on Aug. ... founded in 1915 to promote the practice and awareness ... the interdisciplinary nature of ecology and linking research with ... will be presented at the meeting, including a number ...
... professor and Georgia Research Alliance Eminent Scholar of Molecular ... $9.2 million as part of a major new research ... part of the National Institutes of Health. Dalton,s ... biology, will address the molecular underpinnings of the early ...
... CLEVELAND As Ohio and Michigan fruit and vegetable ... data about the eating choices of Latino migrant children ... gathered this summer will help migrant families understand why ... epidemic and contribute to new interventions to combat this ...
Cached Biology News:ESA to feature wide range of UW-Madison presentations 2ESA to feature wide range of UW-Madison presentations 3ESA to feature wide range of UW-Madison presentations 4ESA to feature wide range of UW-Madison presentations 5ESA to feature wide range of UW-Madison presentations 6ESA to feature wide range of UW-Madison presentations 7ESA to feature wide range of UW-Madison presentations 8UGA researchers win $9.2 million stem cell grant from NIH 2Case Western Reserve University study looks at keeping migrant workers' children healthy 2
(Date:6/1/2015)... June 1, 2015 ... announced the addition of the "Oxidative ... Services), Test Type (Indirect, Enzyme-based, Reactive Oxygen ... End Users - Global Forecast to 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , The ...
(Date:6/1/2015)... June 1, 2015 GenomeDx Biosciences ... analysis platform, successfully classified various subtypes of ... of certain biomarkers, including one type associated ... unique genomic signature has potential as a ... chemotherapy in patients with muscle-invasive bladder cancers ...
(Date:6/1/2015)... June 1, 2015  Novartis is highlighting data ... CTL019, an investigational chimeric antigen receptor (CAR) T ... treatment of specific types of hard-to-treat non-Hodgkin lymphoma. ... University of Pennsylvania,s Perelman School of Medicine (Penn) ... large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Regis ... and manufacturing of chiral stationary phases (CSPs) for ... for its current and presenting solutions for new ... its portfolio. This valuable addition to its core ... effective advantage that can tackle projects for the ...
Breaking Biology Technology:Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3
... Feb. 16, 2011 / PRNewswire/ -- Sigma-Aldrich® ... following executive leadership appointments intended to more closely ... Frank Wicks, President Research, will assume ... including those in Research Essentials, Research Specialties and ...
... PARK, N.C., Feb. 16, 2011 Chimerix, Inc., a ... that it has been awarded a contract by the ... advanced development of Chimerix,s broad spectrum antiviral drug candidate, ... a smallpox release. CMX001 is a ...
... Stryker Corporation,s Orthopaedics division today announced at ... conference the findings of the National Joint Registry ... Trident® Cup, Accolade® Hip Stem and Triathlon® Knee ... revision rates for the most frequently used brands.(1,2,3) ...
Cached Biology Technology:Sigma-Aldrich Announces Organizational Changes 2Sigma-Aldrich Announces Organizational Changes 3Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 2Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 3Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox 4Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales 2Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales 3Stryker Knee and Hip Implants Demonstrate Lowest Revision Rates, According to the National Joint Registry for England and Wales 4
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
... cyclin required for G1-phase progression and is ... cyclin D2 can phosphorylate pRB when associated ... Human, Mouse, and Rat. Others-not tested. ... suited for neutralization of cyclin D2 activity ...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
V beta 5 Purified Anti-Human clone MH3-2, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Biology Products: